Aditxt (ADTX) Expected to Announce Earnings on Wednesday

Aditxt (NASDAQ:ADTX) will likely be posting its results after the market closes on Wednesday, June 3rd. Analysts expect Aditxt to post earnings of ($224,553,600,000.00) per share and revenue of $1.00 million for the quarter.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Aditxt Stock Performance

Shares of ADTX stock opened at $0.25 on Wednesday. The stock has a market cap of $8,398.50, a PE ratio of 0.00 and a beta of 1.08. The business’s fifty day moving average is $13.19 and its 200-day moving average is $236.69. Aditxt has a 1 year low of $0.23 and a 1 year high of $53,451.08.

Analysts Set New Price Targets

Several research firms have recently weighed in on ADTX. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research note on Monday, April 20th. Wall Street Zen raised Aditxt to a “sell” rating in a research note on Saturday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.